Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 189.74

-0.2%

2:55 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tonyt who wrote (22426)	6/17/1998 10:06:00 PM
From: Torben Noerup Nielsen	Read Replies (2) of 32384

>As reported June 2, an FDA expert advisory panel endorsed Ontak When was the last time a drug with a 14-0 vote by the advisory panel did not get approved by the FDA? Yes, I know that there was also a 14-2 vote on the issue of leaving the dosage up to the prescribing physician. This whole thing could be just a matter of clarifying the dosage and the labelling. Does anyone see any real problem here? I can't see what it would be. Frankly, I'm far more excited by the 94% response rate in the cancer study. Yes, those were rodents, but rodents are mammals and even if the carryover to humans drops it to 70% or so, it is still exceptional. Cheers, Torben

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next